Stockscreener 앱 받기
1.22
4.69%
-0.06
시간 외 거래:
1.21
-0.01
-0.82%
전일 마감가:
$1.28
열려 있는:
$1.25
하루 거래량:
247.30K
Relative Volume:
0.44
시가총액:
$31.87M
수익:
$2.83M
순이익/손실:
$-7.95M
주가수익비율:
-0.4536
EPS:
-2.6898
순현금흐름:
$-7.01M
1주 성능:
-3.94%
1개월 성능:
-52.16%
6개월 성능:
-86.59%
1년 성능:
-59.50%
1일 변동 폭
$1.15
$1.28
1주일 범위
$1.14
$1.85
52주 변동 폭
$1.11
$99.75
Novabay Pharmaceuticals Inc Stock (NBY) Company Profile
명칭
Novabay Pharmaceuticals Inc
전화
510-899-8800
주소
2000 Powell Street, Suite 1150, Emeryville, CA
Compare NBY vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NBY
Novabay Pharmaceuticals Inc
|
1.22 | 33.44M | 2.83M | -7.95M | -7.01M | -2.6898 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2019-09-18 | 개시 | Ladenburg Thalmann | Buy |
| 2018-07-06 | 재확인 | H.C. Wainwright | Buy |
| 2017-11-15 | 재확인 | Laidlaw | Buy |
| 2017-06-05 | 개시 | ROTH Capital | Buy |
| 2017-03-27 | 개시 | Laidlaw | Buy |
| 2017-02-06 | 개시 | Rodman & Renshaw | Buy |
| 2016-03-07 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2015-12-14 | 재확인 | Maxim Group | Buy |
| 2015-04-30 | 재개 | Maxim Group | Buy |
| 2013-03-06 | 개시 | Ascendiant Capital Markets | Strong Buy |
| 2008-01-03 | 개시 | Dawson James | Speculative Buy |
모두보기
Novabay Pharmaceuticals Inc 주식(NBY)의 최신 뉴스
Taxes of NovaBay Pharmaceuticals, Inc. – FWB:B9P1 - TradingView
Total assets of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Preferred dividends of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
NovaBay Pharmaceuticals shareholders approve charter amendments and stock issuance By Investing.com - Investing.com Nigeria
Book value per share of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Total debt per share of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Revenue per share of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Gross profit of NovaBay Pharmaceuticals, Inc. – FWB:B9P1 - TradingView
NBY Stock Price, Quote & Chart | NOVABAY PHARMACEUTICALS INC (NYSEARCA:NBY) - ChartMill
NovaBay Pharmaceuticals Approves Issuance of 837 Million Shares and 2026 Equity Incentive Plan in Shareholder Vote - Minichart
NovaBay Pharmaceuticals shareholders approve charter amendments and stock issuance - Investing.com UK
NovaBay Pharma Expands Share Capital and Governance Flexibility - TipRanks
NovaBay (NYSE: NBY) OKs 5B share authorization and charter changes - Stock Titan
Novabay Pharmaceuticals: All six proposals, including share issuances and governance amendments, were approved - TradingView
Novabay Pharmaceuticals: All six proposals, including share issuances and governance changes, were approved - TradingView
NOVABAY PHARMACEUTICALS INC Financial Disclosures & Filings - TradingView
Poplar Point cuts NovaBay (NBY) ownership below 5% reporting level - Stock Titan
Dividend Watch: Will NovaBay Pharmaceuticals Inc stock hit new highs in YEARPortfolio Update Report & Stock Market Timing Techniques - baoquankhu1.vn
Aug Decliners: Will NovaBay Pharmaceuticals Inc stock hit new highs in YEARTrade Entry Report & Daily Volume Surge Trade Alerts - baoquankhu1.vn
NBY Earnings History & Surprises | EPS & Revenue Results | NOVABAY PHARMACEUTICALS INC (NYSEARCA:NBY) - ChartMill
Breakouts Watch: What are the risks of holding NovaBay Pharmaceuticals IncPortfolio Growth Summary & Weekly Market Pulse Updates - baoquankhu1.vn
Gross margin % of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
NBY SEC FilingsNovabay Pharma 10-K, 10-Q, 8-K Forms - Stock Titan
Net current asset value per share of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
NovaBay Pharmaceuticals, Inc. Earnings and Revenue – GETTEX:B9P1 - TradingView
Cash per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
NovaBay Pharmaceuticals (NYSEAMERICAN:NBY) Stock Price Passes Below 50-Day Moving AverageHere's What Happened - MarketBeat
Diluted net income available to common stockholders of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Debt to assets ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Tangible book value per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Net current asset value per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Enterprise value to EBITDA ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Free cash flow per share of NovaBay Pharmaceuticals, Inc. – FWB:B9P1 - TradingView
Operating income of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Price to cash flow ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Diluted shares outstanding of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Total revenue of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Free cash flow of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Enterprise value of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Operating expenses (excl. COGS) of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Number of employees of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Gross margin % of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Operating margin % of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Return on invested capital % of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Diluted earnings per share (diluted EPS) of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
EBITDA of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Free cash flow per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
EBITDA per share of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Total liabilities of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Debt to equity ratio of NovaBay Pharmaceuticals, Inc. – GETTEX:B9P1 - TradingView
Cash from operating activities of NovaBay Pharmaceuticals, Inc. – MUN:B9P1 - TradingView
Novabay Pharmaceuticals Inc (NBY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):